02:52 PM EDT, 08/14/2024 (MT Newswires) -- Verrica Pharmaceuticals ( VRCA ) reported "positive" preliminary topline results from part 2 of a mid-stage trial of VP-315 for the treatment of patients with basal cell carcinoma. Separately, the firm widened its Q2 loss amid higher revenue.

Still, the stock was down 37%, with over 4 million shares traded intraday versus a daily average of roughly 229,000.

Ouster (OUST) posted late Tuesday in-line Q2 sales, but its Q3 revenue outlook missed analyst estimate compiled by Capital IQ.

Shares dropped 26% as intraday trading volume rose to over 4 million from a daily average of about 1.13 million.

Siyata Mobile ( SYTA ) said Wednesday it has priced a public offering of shares and pre-funded warrants to raise about $4 million.

Shares slumped 21% as intraday trading volume jumped to over 414,000 from a daily average of roughly 237,000.

Price: 3.32, Change: -1.95, Percent Change: -37.02